Year |
Citation |
Score |
2020 |
Jargaud V, Bour S, Tercé F, Collet X, Valet P, Bouloumié A, Guillemot JC, Mauriège P, Jalkanen S, Stolen C, Salmi M, Smith DJ, Carpéné C. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity. Journal of Physiology and Biochemistry. PMID 32712883 DOI: 10.1007/S13105-020-00756-Y |
0.656 |
|
2009 |
Bour S, Caspar-Bauguil S, Iffiú-Soltész Z, Nibbelink M, Cousin B, Miiluniemi M, Salmi M, Stolen C, Jalkanen S, Casteilla L, Pénicaud L, Valet P, Carpéné C. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition. The American Journal of Pathology. 174: 1075-83. PMID 19218346 DOI: 10.2353/Ajpath.2009.080612 |
0.664 |
|
2007 |
Bour S, Prévot D, Guigné C, Stolen C, Jalkanen S, Valet P, Carpéné C. Semicarbazide-sensitive amine oxidase substrates fail to induce insulin-like effects in fat cells from AOC3 knockout mice. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 829-33. PMID 17406965 DOI: 10.1007/S00702-007-0671-2 |
0.567 |
|
2006 |
Marttila-Ichihara F, Smith DJ, Stolen C, Yegutkin GG, Elima K, Mercier N, Kiviranta R, Pihlavisto M, Alaranta S, Pentikäinen U, Pentikäinen O, Fülöp F, Jalkanen S, Salmi M. Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo. Arthritis and Rheumatism. 54: 2852-62. PMID 16947396 DOI: 10.1002/Art.22061 |
0.642 |
|
2006 |
Yu PH, Lu LX, Fan H, Kazachkov M, Jiang ZJ, Jalkanen S, Stolen C. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation. The American Journal of Pathology. 168: 718-26. PMID 16507887 DOI: 10.2353/Ajpath.2006.050970 |
0.62 |
|
2005 |
Kirton CM, Laukkanen ML, Nieminen A, Merinen M, Stolen CM, Armour K, Smith DJ, Salmi M, Jalkanen S, Clark MR. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy. European Journal of Immunology. 35: 3119-30. PMID 16224816 DOI: 10.1002/Eji.200535300 |
0.606 |
|
2005 |
Stolen CM, Marttila-Ichihara F, Koskinen K, Yegutkin GG, Turja R, Bono P, Skurnik M, Hänninen A, Jalkanen S, Salmi M. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity. 22: 105-15. PMID 15664163 DOI: 10.1016/J.Immuni.2004.12.006 |
0.668 |
|
2004 |
Stolen CM, Yegutkin GG, Kurkijärvi R, Bono P, Alitalo K, Jalkanen S. Origins of serum semicarbazide-sensitive amine oxidase. Circulation Research. 95: 50-7. PMID 15178639 DOI: 10.1161/01.Res.0000134630.68877.2F |
0.6 |
|
2004 |
Stolen CM, Madanat R, Marti L, Kari S, Yegutkin GG, Sariola H, Zorzano A, Jalkanen S. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 702-4. PMID 14977883 DOI: 10.1096/fj.03-0562fje |
0.592 |
|
2002 |
Salmi M, Stolen C, Jousilahti P, Yegutkin GG, Tapanainen P, Janatuinen T, Knip M, Jalkanen S, Salomaa V. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. The American Journal of Pathology. 161: 2255-62. PMID 12466139 DOI: 10.1016/S0002-9440(10)64501-4 |
0.627 |
|
Show low-probability matches. |